Frederik Wenz Selected Research

capecitabine-irinotecan combination

8/2009	Cetuximab in combination with capecitabine, irinotecan, and radiotherapy for patients with locally advanced rectal cancer: results of a Phase II MARGIT trial.
3/2009	Can dynamic MR imaging predict response in patients with rectal cancer undergoing cetuximab-based neoadjuvant chemoradiation?
3/2005	Phase I trial of capecitabine and weekly irinotecan in combination with radiotherapy for neoadjuvant therapy of rectal cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Frederik Wenz Research Topics

Disease

110	Neoplasms (Cancer) 01/2022 - 08/2002
89	Breast Neoplasms (Breast Cancer) 01/2022 - 04/2003
23	Glioblastoma (Glioblastoma Multiforme) 01/2021 - 01/2005
22	Neoplasm Metastasis (Metastasis) 05/2019 - 05/2002
17	Prostatic Neoplasms (Prostate Cancer) 08/2021 - 06/2005
17	Rectal Neoplasms (Rectal Cancer) 01/2020 - 11/2002
9	Fibrosis (Cirrhosis) 01/2021 - 10/2006
8	Carcinoma (Carcinomatosis) 01/2021 - 01/2003
8	Stomach Neoplasms (Stomach Cancer) 01/2021 - 08/2003
8	Sarcoma (Soft Tissue Sarcoma) 05/2020 - 08/2004
7	Anus Neoplasms (Anal Cancer) 04/2016 - 08/2007
6	Brain Neoplasms (Brain Tumor) 02/2020 - 05/2004
6	Wounds and Injuries (Trauma) 01/2020 - 01/2012
6	Lung Neoplasms (Lung Cancer) 04/2018 - 08/2010
6	AIDS-Related Complex (ARC) 03/2016 - 07/2004
5	Residual Neoplasm 01/2019 - 09/2009
5	Colorectal Neoplasms (Colorectal Cancer) 02/2014 - 11/2002
4	Cardiotoxicity 01/2021 - 04/2009
4	Pain (Aches) 11/2020 - 07/2012
4	Ductal Carcinoma 01/2020 - 02/2014
3	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 12/2012 - 05/2002
2	Adenocarcinoma 09/2020 - 11/2009
2	Endometrial Neoplasms (Endometrial Cancer) 09/2020 - 07/2009
2	Second Primary Neoplasms (Neoplasms, Second) 10/2019 - 03/2014
2	Telangiectasis (Telangiectasia) 01/2019 - 03/2008
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2018 - 03/2012
2	Margins of Excision 01/2018 - 08/2014
2	Radiation Fibrosis Syndrome (Radiation Fibrosis) 10/2017 - 03/2016
2	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2017 - 12/2007
2	Glioma (Gliomas) 07/2016 - 09/2009
2	Diarrhea 01/2015 - 08/2009
2	Head and Neck Neoplasms (Head and Neck Cancer) 08/2014 - 12/2011
2	Proctitis 06/2012 - 08/2009
2	Leukemia 01/2012 - 10/2009
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 03/2011 - 10/2009

Drug/Important Bio-Agent (IBA)

9	Capecitabine (Xeloda)FDA Link 01/2016 - 03/2005
8	Temozolomide (Temodar)FDA LinkGeneric 04/2017 - 09/2009
7	Cetuximab (Erbitux)FDA Link 11/2017 - 12/2006
6	Irinotecan (Camptosar)FDA LinkGeneric 01/2015 - 03/2005
5	Hormones (Hormone)IBA 04/2020 - 11/2013
5	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 05/2006
5	plerixafor FDA Link 02/2014 - 01/2009
4	Pharmaceutical PreparationsIBA 01/2022 - 12/2013
4	Sunitinib (Sutent)FDA Link 03/2020 - 09/2013
4	ErbB Receptors (EGF Receptor)IBA 11/2017 - 11/2011
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 07/2009
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 04/2008
3	ParaffinIBA 01/2016 - 10/2012
3	CytokinesIBA 06/2012 - 04/2004
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2012 - 06/2007
2	RNA (Ribonucleic Acid)IBA 01/2021 - 01/2018
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 09/2020 - 01/2009
2	Leucovorin (Folinic Acid)FDA Link 09/2020 - 11/2002
2	Imatinib Mesylate (Gleevec)FDA Link 01/2020 - 10/2009
2	GoldIBA 01/2019 - 01/2018
2	MetalsIBA 01/2019 - 05/2015
2	Diacylglycerol KinaseIBA 10/2017 - 03/2016
2	ArtesunateIBA 04/2017 - 01/2017
2	Peptides (Polypeptides)IBA 07/2016 - 04/2008
2	MethyltransferasesIBA 07/2016 - 10/2012
2	Messenger RNA (mRNA)IBA 01/2016 - 12/2008
2	Thalidomide (Thalomid)FDA Link 04/2014 - 09/2007
2	CXCR4 Receptors (CXCR4 Receptor)IBA 02/2014 - 04/2013
2	Contrast MediaIBA 03/2011 - 03/2009
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2009 - 06/2007
1	Indicators and Reagents (Reagents)IBA 01/2021
1	Biological ProductsIBA 01/2021
1	AnthracyclinesIBA 01/2021
1	Docetaxel (Taxotere)FDA Link 09/2020
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2020

Therapy/Procedure

184	Radiotherapy 01/2022 - 04/2003
61	Therapeutics 01/2021 - 11/2002
35	Segmental Mastectomy (Lumpectomy) 01/2021 - 04/2003
21	Drug Therapy (Chemotherapy) 09/2020 - 05/2002
20	Chemoradiotherapy 09/2020 - 01/2003
19	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 01/2022 - 05/2009
17	Neoadjuvant Therapy 01/2021 - 03/2005
7	Image-Guided Radiotherapy 08/2021 - 12/2008
7	Kyphoplasty 11/2020 - 02/2010
7	Brachytherapy 11/2020 - 04/2006
6	Adjuvant Chemotherapy 04/2020 - 01/2007
6	Adjuvant Radiotherapy 01/2020 - 11/2003
5	Prostatectomy (Retropubic Prostatectomy) 06/2019 - 03/2011
5	Adjuvant Chemoradiotherapy 04/2015 - 07/2004
4	Mastectomy (Mammectomy) 01/2020 - 09/2007
4	Conformal Radiotherapy 07/2017 - 12/2008
4	Cranial Irradiation 12/2012 - 05/2002
3	Combined Modality Therapy 01/2019 - 09/2013
3	Re-Irradiation 03/2016 - 07/2011
3	capecitabine-irinotecan combination 08/2009 - 03/2005
2	Inlays (Inlay) 01/2019 - 05/2016
2	Aftercare (After-Treatment) 11/2018 - 10/2018
2	Palliative Care (Palliative Therapy) 10/2017 - 02/2010
2	Immunotherapy 01/2017 - 01/2017
2	Particle Accelerators 03/2016 - 11/2010
2	Drug Tapering 09/2011 - 04/2009
2	Transplantation 03/2011 - 01/2009
2	Colostomy 05/2008 - 08/2007
1	Precision Medicine 01/2021
1	Induction Chemotherapy 09/2020